http://www.fresenius.com en-us Wed, 01 Apr 2020 00:00:00 +0200 Wed, 01 Apr 2020 00:00:00 +0200 Wed, 01 Apr 2020 08:00:00 +0100 <![CDATA[Fresenius Medical Care partners with other dialysis providers to combat coronavirus pandemic in the U.S.]]> The collaboration aims to support the broader kidney care community in the United States by offering isolation capacity for dialysis patients who are or may be COVID-19 positive.

]]>
Tue, 31 Mar 2020 08:00:00 +0100 <![CDATA[Fresenius successfully places bonds with a volume of 750 million euros]]> The proceeds will be used for general corporate purposes, including refinancing of existing financial liabilities.

]]>
Mon, 30 Mar 2020 08:00:00 +0100 <![CDATA[Fresenius Medical Care postpones 2020 Annual General Meeting]]> Fresenius Medical Care postpones its 2020 Annual General Meeting, which was scheduled for May 19, to a later date this year due to the coronavirus pandemic.

]]>
Mon, 30 Mar 2020 08:00:00 +0100 <![CDATA[Fresenius postpones 2020 Annual General Meeting]]> Due to the coronavirus pandemic, Fresenius SE & Co. KGaA postpones its Annual General Meeting scheduled for 20 May 2020 to a later date within the current financial year.

]]>
Fri, 27 Mar 2020 08:00:00 +0100 <![CDATA[Fresenius takes comprehensive measures to combat COVID 19 pandemic in Germany]]> Helios Germany is undertaking comprehensive measures to combat the COVID-19 pandemic. In accordance with the German government’s request, surgical procedures are being delayed whenever medically justifiable. The freed-up capacity is reserved for the imminent treatment of COVID-19 patients.

]]>
Tue, 24 Mar 2020 08:00:00 +0100 <![CDATA[Fresenius Kabi resumes normal operations in China]]> With virtually all of Fresenius Kabi’s manufacturing staff in China returning to work post government-imposed COVID-19 quarantine restrictions, the company is ramping-up production back to normal levels. With a further stabilization of the situation, Fresenius Kabi also expects a gradual resumption of its sales force activities in China. Even though Fresenius Kabi faced challenges due to the COVID-19 pandemic and the quarantine measures, there was no major interruption of production. Thus, the company can supply the Chinese population with essential pharmaceuticals and medical devices.

]]>
Fri, 20 Mar 2020 08:00:00 +0100 <![CDATA[Fresenius Helios makes significant contribution to combating COVID-19 crisis in Spain]]> Quirónsalud, the largest private hospital group in Spain and part of Fresenius Helios, is fully committed to supporting the national effort against COVID-19 with all available resources.

]]>
Wed, 18 Mar 2020 08:00:00 +0100 <![CDATA[Fresenius subsidiary Curalie acquires Digitale Gesundheitsgruppe]]> Curalie, a subsidiary of Fresenius, has acquired Digitale Gesundheitsgruppe (DGG), one of its main competitors in Germany. Curalie and DGG both develop digital healthcare offerings to help patients with chronic illnesses. DGG targets family and specialist physicians with its “TeLiPro” telemedicine platform, while Curalie develops digital solutions for rehabilitation and aftercare. Combining the two companies creates the first provider that in all sectors of healthcare can digitally support patients during outpatient and inpatient care and through to aftercare.

]]>
Wed, 18 Mar 2020 08:00:00 +0100 <![CDATA[Fresenius annual report 2019 online available]]> Our Annual Report 2019 is now available as a full-content PDF download and as an online short-version with the highlights. Annual Report (PDF)  Online short-version

]]>
Tue, 25 Feb 2020 08:00:00 +0100 <![CDATA[FDA clears Fresenius Medical Care’s Novalung for treatment of acute respiratory and cardiopulmonary failure]]> Fresenius Medical Care today announced that the U.S. Food and Drug Administration (FDA) has cleared Novalung®, a heart and lung support system for the treatment of acute respiratory or cardiopulmonary failure.

]]>
Mon, 24 Feb 2020 08:00:00 +0100 <![CDATA[Potentialpark 2020 study shows Fresenius has Germany’s best online offering for job applicants]]> The market research institute Potentialpark has honored the global healthcare group Fresenius for the ninth consecutive year as the German company with the best overall Internet offering for job applicants.

]]>
Thu, 20 Feb 2020 08:00:00 +0100 <![CDATA[Fresenius Kabi and Vifor Pharma create joint venture in China for i.v. iron portfolio ]]> Fresenius Kabi and Vifor Pharma have formed a joint venture in China to provide patients access to vital blood management treatment. It will combine Vifor Pharma’s leading intravenous drug portfolio for the treatment of iron deficiency with Fresenius Kabi’s strong and long-year presence in the market to benefit both patients and the healthcare system in China. The joint venture will focus on marketing, market access and medical affairs activities whereas Fresenius Kabi will be fully responsible for the commercialization of the intravenous iron portfolio. The joint company will be 55% owned by Vifor Pharma and 45% by Fresenius Kabi. Financial terms were not disclosed.

]]>
Thu, 20 Feb 2020 08:00:00 +0100 <![CDATA[Fresenius reports 16th consecutive record year – After significant investments in 2019, company expects healthy growth in 2020 and confirms medium-term growth targets]]> Stephan Sturm, CEO of Fresenius, said: “2019 was a good year for Fresenius. A year of challenges, but also of many successes. We have treated even more patients, launched new products, and increased our sales to more than 35 billion euros. (...)"

]]>
Wed, 19 Feb 2020 08:00:00 +0100 <![CDATA[Fresenius Medical Care achieves 2019 guidance and confirms 2020 outlook of sustainable, profitable growth]]> Rice Powell, Chief Executive Officer of Fresenius Medical Care, said: “2019 was a successful year for Fresenius Medical Care. We achieved our revenue and net income targets and are therefore proposing our 23rd consecutive dividend increase. (...)"
 

]]>
Wed, 19 Feb 2020 08:00:00 +0100 <![CDATA[Fresenius Helios acquires first hospital in Bogotá, continuing expansion in Colombia’s private hospital market]]> Quirónsalud, the largest private hospital group in Spain and part of Fresenius Helios, has signed an agreement to acquire Clínica de la Mujer in Bogotá, further expanding the company’s presence in Colombia’s attractive private hospital market.

]]>
Fri, 24 Jan 2020 08:00:00 +0100 <![CDATA[Fresenius Kabi inaugurates €30 million expansion of transfusion and apheresis disposables plant in Dominican Republic]]> Top government and company officials joined local executives and employees as Fresenius Kabi inaugurated yesterday the major expansion of the company’s production site in the Dominican Republic. 

]]>
Tue, 21 Jan 2020 08:00:00 +0100 <![CDATA[Fresenius Kabi enters into joint venture to advance new cell and gene therapies]]> Fresenius Kabi, Bio-Techne and Wilson Wolf have formed a new joint venture to support researchers and biopharmaceutical companies in the field of cell and gene therapy. The joint venture is owned equally by the three partners and will focus on providing scalable manufacturing technologies and processes needed to develop and commercialize new cell and gene therapies. No financial terms were disclosed.

]]>
Thu, 16 Jan 2020 08:00:00 +0100 <![CDATA[Fresenius Helios trains doctors in antibiotics management]]> Fresenius Helios has started training experts in antibiotics management to combat the growing threat from multi-resistant bacteria. In the coming years, more than 600 doctors will be trained at the company’s 86 hospitals in Germany on the correct way to handle antibiotics. These doctors will raise awareness of the problem among colleagues and be available for consultations with them. In addition, Fresenius Helios is introducing a system under which each hospital will report on its antibiotics usage.

]]>
Tue, 07 Jan 2020 08:00:00 +0100 <![CDATA[Fresenius successfully places bonds with a volume of 750 million euros]]> Mon, 23 Dec 2019 08:00:00 +0100 <![CDATA[Fresenius Helios acquires leading private hospital in Colombia]]> Quirónsalud, the largest private hospital group in Spain and part of Fresenius Helios, has signed an agreement to acquire Centro Médico Imbanaco (CMI) in Cali, further expanding the company’s presence in Colombia’s attractive private hospital market.

]]>